ESTEVE CDMO
Global CDMO expanding manufacturing in the USA and China, with early development capabilities added in the US
ESTEVE CDMO is adding manufacturing capacity in the USA and China, including a $33 million expansion at its Morton Grove, Illinois site. Its China investment adds three manufacturing workshops with 250 m³ of total reaction volume, and its US assets add early development capabilities. Headquartered in Morton Grove, United States.
About this organization
ESTEVE CDMO
ESTEVE CDMO is the contract development and manufacturing business of ESTEVE, an international specialty pharmaceutical group with a strong European presence. The CDMO business is presented as a separate service line with its own contact page.
Manufacturing footprint
- China: ESTEVE CDMO has announced a investment of more than $80 million in a new site in China, adding three manufacturing workshops and 250 m³ of total reaction volume to its global manufacturing network. The company notes more than 20 years of manufacturing presence in China.
- United States: ESTEVE CDMO has announced an additional $17.5 million investment in its Morton Grove, Illinois site, bringing the total announced investment there to $33 million.
Development capabilities
- The company reports that its CDMO business is growing with new assets in the USA that add early development capabilities.
Corporate context
- ESTEVE reports that expansion in both its Pharma and CDMO businesses has supported double-digit growth in net revenues and EBITDA.
- The company has achieved B Corp Certification.
Locations
Morton Grove
Morton Grove · Illinois · USA
China manufacturing site
China
Recent news about ESTEVE CDMO
Submit a verified review for this organization.
Markdown mirror: /companies/esteve-cdmo.md